1,470 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

LLY0

Eli Lilly
US$21.0013.5%n/aUS$700.2bUS$22.35PE130.2xE27.2%0.7%

LLY

Eli Lilly
US$698.00-1.3%107.4%US$700.2bUS$742.85PE130.2xE27.2%0.7%

LLY

Eli Lilly
US$694.00-3.5%107.7%US$682.1bUS$738.59PE130.2xE27.2%0.7%

NOV

Novo Nordisk
kr.114.64-1.7%57.6%kr.3.8tkr.121.58PE45.7xE14.1%1.1%

NOVA

Novo Nordisk
kr.114.50-2.1%54.2%kr.3.8tkr.121.43PE45.7xE14.1%1.1%

NOV

Novo Nordisk
kr.116.02-1.5%54.9%kr.3.8tkr.123.04PE45.7xE14.1%1.1%

JNJ

Johnson & Johnson
US$140.18-2.7%-5.9%US$367.0bUS$161.42PE27.5xE9.7%3.1%

JNJ0

Johnson & Johnson
US$13.60-3.5%n/aUS$365.3bUS$15.66PE27.5xE9.7%3.1%

JNJ

Johnson & Johnson
US$140.34-3.7%-7.3%US$365.3bUS$161.60PE27.5xE9.7%3.1%

6MK

Merck
US$115.60-4.1%12.2%US$320.5bUS$124.37PE879.2xE25.3%2.4%

6MK

Merck
US$116.40-4.0%12.1%US$320.5bUS$125.23PE879.2xE25.3%2.4%

4AB0

AbbVie
US$15.90-6.5%n/aUS$300.7bUS$17.18PE62.5xE22.7%3.6%

4AB

AbbVie
US$155.50-6.8%4.7%US$300.7bUS$168.06PE62.5xE22.7%3.6%

4AB

AbbVie
US$155.60-7.1%4.5%US$300.7bUS$168.17PE62.5xE22.7%3.6%

TN80

Thermo Fisher Scientific
US$14.101.4%n/aUS$220.9bUS$14.53PE37.5xE10.6%0.3%

TN8

Thermo Fisher Scientific
US$540.401.9%1.9%US$220.9bUS$556.71PE37.5xE10.6%0.3%

TN8

Thermo Fisher Scientific
US$540.302.4%2.5%US$220.9bUS$556.61PE37.5xE10.6%0.3%

ZEG

AstraZeneca
UK£125.200.2%-5.7%UK£166.0bUK£149.40PE35.3xE16.3%2.1%

ZEGA

AstraZeneca
UK£62.00-0.8%-6.1%UK£166.0bUK£73.99PE35.3xE16.3%2.1%

ZEG

AstraZeneca
UK£125.650.8%-5.1%UK£166.0bUK£149.94PE35.3xE16.3%2.1%

NOTA

Novartis
CHF88.803.7%3.5%CHF189.1bCHF100.42PE24.4xE9.1%3.8%

RHO6

Roche Holding
CHF28.20-5.7%-19.4%CHF178.5bCHF35.83PE15.4xE8.3%4.3%

DAP

Danaher
US$230.001.3%0.4%US$185.0bUS$242.43PE44xE11.3%0.4%

DAP

Danaher
US$227.60-0.4%-0.9%US$180.9bUS$239.90PE44xE11.3%0.4%
Page 1 of 62
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.